Literature DB >> 2316703

ANG II inhibits calcium-activated potassium channels from coronary smooth muscle in lipid bilayers.

L Toro1, M Amador, E Stefani.   

Abstract

Angiotensin II (ANG II) is a powerful vasoconstrictor of coronary vessels and other smooth muscles. One of the actions of ANG II is the inhibition of K+ currents, possibly contributing to depolarization and contraction. Therefore, we investigated the role of ANG II on the regulation of K+ channels at the single-channel level. We studied its effect on calcium-activated potassium (KCa) channels (congruent to 250 pS) from coronary smooth muscle incorporated into lipid bilayers. KCa channels were sensitive to externally applied ANG II at voltages from -20 to -70 mV and pCa between 6.5 and 4. The dose-response curve gave a concentration of half-inhibition (Ki1/2) of 58 nM and a Hill coefficient of 2.2, indicating a minimum of two sites in the process. ANG II modified the open and closed states of the channel, affecting their proportions and their values. In addition, a new much slower (congruent to 1 s) closed or "blocked" state appeared. We conclude that one of the mechanisms by which ANG II causes vasoconstriction of the coronary vessels is a direct inhibition of KCa channels contributing to depolarization and contraction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2316703     DOI: 10.1152/ajpheart.1990.258.3.H912

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  25 in total

1.  Influence of Ca(2+)-activated K(+) channels on rat renal arteriolar responses to depolarizing agonists.

Authors:  R W Fallet; J P Bast; K Fujiwara; N Ishii; S C Sansom; P K Carmines
Journal:  Am J Physiol Renal Physiol       Date:  2001-04

2.  Thromboxane A2 receptor and MaxiK-channel intimate interaction supports channel trans-inhibition independent of G-protein activation.

Authors:  Min Li; Yoshio Tanaka; Abderrahmane Alioua; Yong Wu; Rong Lu; Pallob Kundu; Enrique Sanchez-Pastor; Jure Marijic; Enrico Stefani; Ligia Toro
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-19       Impact factor: 11.205

Review 3.  Calcium-activated K+ channels: metabolic regulation.

Authors:  L Toro; E Stefani
Journal:  J Bioenerg Biomembr       Date:  1991-08       Impact factor: 2.945

4.  Impaired function of coronary BK(Ca) channels in metabolic syndrome.

Authors:  Léna Borbouse; Gregory M Dick; Shinichi Asano; Shawn B Bender; U Deniz Dincer; Gregory A Payne; Zachary P Neeb; Ian N Bratz; Michael Sturek; Johnathan D Tune
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-11       Impact factor: 4.733

5.  Angiotensin II stimulates internalization and degradation of arterial myocyte plasma membrane BK channels to induce vasoconstriction.

Authors:  M Dennis Leo; Simon Bulley; John P Bannister; Korah P Kuruvilla; Damodaran Narayanan; Jonathan H Jaggar
Journal:  Am J Physiol Cell Physiol       Date:  2015-07-15       Impact factor: 4.249

Review 6.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 7.  Potassium Channels in Regulation of Vascular Smooth Muscle Contraction and Growth.

Authors:  W F Jackson
Journal:  Adv Pharmacol       Date:  2016-08-17

8.  Angiotensin II inhibits rat arterial KATP channels by inhibiting steady-state protein kinase A activity and activating protein kinase Ce.

Authors:  Y Hayabuchi; N W Davies; N B Standen
Journal:  J Physiol       Date:  2001-01-15       Impact factor: 5.182

9.  Angiotensin II inhibition of ATP-sensitive K+ currents in rat arterial smooth muscle cells through protein kinase C.

Authors:  M Kubo; J M Quayle; N B Standen
Journal:  J Physiol       Date:  1997-09-15       Impact factor: 5.182

10.  BK Channels in Cardiovascular Diseases and Aging.

Authors:  João Luis Carvalho-de-Souza; Wamberto A Varanda; Rita C Tostes; Andreia Z Chignalia
Journal:  Aging Dis       Date:  2012-12-07       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.